Development Software Engineering Software Review Study 
Xconomy
OCTOBER 5, 2016
The first round of pitches are due this week. But this decade’s frenzied development of the editing system CRISPR-Cas9 could soon bring a wave of human therapies into clinical trials. Editas, which could be the first of the group to begin human studies, wants to start a trial for a rare eye disease in 2017.
Both Sides of the Table
APRIL 5, 2010
TWTFelipe is the founder of TWTApps , who had developed some really cool add-on applications for Twitter to extend its functionality. He came to the United States in 2001 to study Software Engineering at Auburn University. We then moved our Chief Software Architect over. Felipe grew up in Brazil. More red tape.
Expert insights. Personalized for you.
111 
Let's personalize your content